Cancellation of presentations at investor conferences is often considered a negative trigger for company shares, as investors believe there is no smoke without fire. As recently as on November 4 this year, ...
- Accesswire•yesterdayINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
IRVINE, CA / ACCESSWIRE / December 7, 2016 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") ...
- Business Wire•2 days agoThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Alexion Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Alexion Pharmaceuticals, Inc. securities between February 10, 2014 and November 9, 2016, inclusive .
ALXN : Summary for Alexion Pharmaceuticals, Inc. - Yahoo Finance
Alexion Pharmaceuticals, Inc. (ALXN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||123.17 - 126.69|
|52 Week Range||110.56 - 193.45|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||76.83|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|